Bevacizumab-induced nasal septum perforation

Oncologist. 2006 Jan;11(1):85-6. doi: 10.1634/theoncologist.11-1-85.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents / adverse effects*
  • Bevacizumab
  • Humans
  • Male
  • Middle Aged
  • Nasal Septum*
  • Nose Diseases / chemically induced*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Bevacizumab